01020304
Abemaciclib CAS No.1231929-97-7 Pharmaceutical Intermediates
01
Physical and Chemical Properties
7 Jan 2019
Abemaciclib is a potent and selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6), which are critical regulators of cell cycle progression. This compound has gained significant attention in the pharmaceutical industry for its efficacy in treating certain types of breast cancer. Our Abemaciclib is manufactured under stringent quality control measures to ensure the highest purity and effectiveness, making it an ideal choice for pharmaceutical companies and research institutions.
02
Physical and Chemical Properties
7 Jan 2019
Abemaciclib is characterized by its white to off-white crystalline powder form. It has a molecular formula of C27H32F2N8 and a molecular weight of 506.60 g/mol. The compound is soluble in DMSO and slightly soluble in water, which makes it versatile for various pharmaceutical formulations. Its melting point ranges between 200-210°C, ensuring stability under standard storage conditions.
03
Advantages of Our Abemaciclib
7 Jan 2019
1. High Purity: Our Abemaciclib boasts a purity level of over 99%, ensuring maximum efficacy and safety for pharmaceutical applications.
2. Consistent Quality: Produced in our integrated production and trade factory, we maintain strict quality control protocols to deliver consistent and reliable products.
3. Competitive Pricing: By managing both production and trade, we offer competitive pricing without compromising on quality.
4. Reliable Supply Chain: Our robust supply chain ensures timely delivery and availability, supporting your production schedules and research timelines.
5. Compliance with International Standards: Our manufacturing processes comply with international quality standards, including GMP, ensuring that our Abemaciclib meets the highest industry benchmarks.
04
Applications in the Pharmaceutical Industry
7 Jan 2019
Abemaciclib is primarily used in the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer. It works by inhibiting CDK4/6, thereby preventing cancer cells from proliferating. This makes it a critical component in targeted cancer therapies, often used in combination with other treatments such as hormone therapy.
04
Why Choose Our Abemaciclib?
7 Jan 2019
1. Integrated Production and Trade: Our factory integrates both production and trade, allowing us to control the entire supply chain from raw material sourcing to final product delivery. This integration ensures that we can offer high-quality products at competitive prices.
2. State-of-the-Art Facilities: Our production facilities are equipped with the latest technology and operated by a team of experienced professionals. This ensures that every batch of Abemaciclib meets our stringent quality standards.
3. Expertise and Experience: With years of experience in the pharmaceutical industry, we understand the specific needs and challenges faced by our clients. Our expertise allows us to provide tailored solutions and support to help you achieve your goals.
4. Customer-Centric Approach: We prioritize our customers' needs and strive to build long-term partnerships. Our dedicated customer service team is always available to assist you with any inquiries or issues.
04
Conclusion
7 Jan 2019
Our Abemaciclib is a high-quality, reliable, and competitively priced product designed to meet the needs of the pharmaceutical industry. With its superior physical and chemical properties, consistent quality, and compliance with international standards, it is an excellent choice for pharmaceutical companies and research institutions. Trust us to be your partner in delivering effective and innovative cancer treatments. Contact us today to learn more about our Abemaciclib and how we can support your pharmaceutical needs.
description2